S-adenosyl-l-homocysteine


Also found in: Wikipedia.

S-a·den·o·syl-l-ho·mo·cys·te·ine

(a-den'ō-sil-hō-mō-sis'te-ēn),
Compound formed by the demethylation of S-adenosyl-l-methionine; produced by many methyltransferases.
References in periodicals archive ?
The presence of caffeic acid or chlorogenic acid inhibited DNA methylation predominantly through a non-competitive mechanism, and this inhibition was largely due to the increased formation of S-adenosyl-L-homocysteine (SAH, a potent inhibitor of DNA methylation), resulting from the catechol-O-methyltransferase (COMT)-mediated O-methylation of these dietary catechols.
D,L-Homocysteine and S-adenosyl-l-homocysteine hydrolase from rabbit erythrocytes were obtained from Sigma, and Tris base was obtained from Sigma-Aldrich.
Synthesis and antiviral activity of some new S-adenosyl-L-homocysteine derivatives.
The IMMULITE 2000 performs an on-line one-cycle sample pretreatment of patient plasma or serum with S-adenosyl-L-homocysteine (SAH) hydrolase and dithiothreitol (DTT) solution in a reaction tube containing no bead.
Both methods are based on enzymatic conversion of homocysteine to S-adenosyl-L-homocysteine, which is subsequently detected by a competitive immunoassay.
This assay involves the initial reduction of Hcy, mixed-disulfide, and protein-bound Hcy to free Hcy with dithiothreitol, followed by conversion to S-adenosyl-L-homocysteine (SAH) by bovine SAH hydrolase and excess adenosine.
Both assays are based on enzymatic conversion of Hcy to S-adenosyl-L-homocysteine (SAH) by the action of SAH hydrolase (SAHase; EC 3.
The "Abbott Homocysteine (HCY) assay" is a fluorescence polarization immunoassay based on the highly selective enzymatic conversion of homocysteine to S-adenosyl-L-homocysteine, which is then recognized by a monoclonal antibody (2).
This assay is based on enzymatic conversion of tHcy (after reduction and release of endogenous homocysteine from proteins and/or disulfides) to S-adenosyl-L-homocysteine (SAH) by the action of SAH hydrolase (EC 3.
The method is based on enzymatic conversion of Hcy to S-adenosyl-L-homocysteine (SAH) by the action of SAH hydrolase (SAHase; EC 3.